United States Antimony (UAMY) Reports Higher Sales And Wider Losses, Is The Valuation Too Cheap?

Detailed summary

United States Antimony (UAMY) is back in focus after its third quarter 2026 report showed higher sales of US$10.13 million, alongside a wider net loss of US$9.53 million and…

United States Antimony (UAMY) is back in focus after its third quarter 2026 report showed higher sales of US$10.13 million, alongside a wider net loss of US$9.53 million and deeper per share losses.

Recent trading tells a mixed story for United States Antimony. The share price at US$3.09 has climbed with a 1 day share price return of 6.2% and a 30 day gain of 10.8%. However, momentum has faded over the year, with the year to date share price return down 47.9% and the 1 year total shareholder return down 58.1%. This is set against a very large 3 year total shareholder return above 9x that still reflects how much sentiment had improved from earlier levels before this recent pullback.

Scan the antimony space beyond United States Antimony and compare its recent pullback with 33 best rare earth metal stocks that may offer different risk and return profiles.

Bulls point to United States Antimony's higher sales and long term return, while bears focus on deeper losses and guidance uncertainty. Which story does the current valuation really support?

United States Antimony closed at $3.09, while the analyst consensus Narrative on Simply Wall St estimates fair value at $10.92. The story hinges on whether that gap can be justified by execution on contracts, pricing and costs.

Still, the narrative on United States Antimony can crack if weak antimony pricing persists or if higher fixed costs continue to translate into ongoing operating losses.

Find out about the key risks to this United States Antimony narrative.

The cash flow story for United States Antimony looks optimistic, with the stock trading 68.7% below the SWS estimate of future cash flow value at $9.86. Yet the P/S ratio at 12.2x is far above the industry at 2.7x, peers at 3.8x and the fair ratio at 3.6x. That gap raises a practical question for investors: Is the market already baking in a lot of success before it shows up in the income statement?

For a closer look at how current pricing stacks up against sales based metrics…

Opening of the article, excerpted from Yahoo Finance. To read the rest, open the article on the publisher's site.